The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver: thermospray liquid chromatography-mass spectrometry identification of metabolites

References

• Alving A. S., Pullman T. N., Craige B., Jr., Jones R., Jr., Whorton C. M., Eichelberger L. The clinical trial of eighteen analogues of pamaquin (Plasmochin) in vivax malaria (Chesson strain). Journal of Clinical Investigation 1948; 27: 34–45
   Web of Science ®Google Scholar
• Anders J. C., Chung H., Theoharides A. D. Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog. Fundamental and Applied Toxicology 1988; 10: 270–275
   PubMedGoogle Scholar
• Isolated Liver Perfusion and Its Applications, I. Bartosek, A. Guaitani, L. L. Miller. Raven Press, New York 1973
   Google Scholar
• Belinsky S. A., Reinke L. A., Kauffman F. C., Thurman R. G. Inhibition of mixed-function oxidations of p-nitroanisole in perfused rat liver by 2,4-dinitrophenol. Archives of Biochemistry and Biophysics 1980; 204: 207–213
   PubMed Web of Science ®Google Scholar
• Berman J. D. Leishmaniasis methods Current Therapy, H. W. Conn. W. B. Saunders, Philadelphia 1983; 27–29
   Google Scholar
• Berman J. D., Lee L. S. Activity of 8-aminoquinolines against Leishmania tropica within human macrophages in vitro. Americal Journal of Tropical Medicine and Hygiene 1983; 32: 753–759
   PubMed Web of Science ®Google Scholar
• Betowski L. D., Korfmacher W. A., Lay J. O, Jr., Potter D. W., Hinson J. A. Direct analysis of rat bile for acetaminophen and two of its conjugated metabolites via Thermospray liquid chromatography/mass spectrometry. Biomedical and Environmental Mass Spectrometry 1987; 14: 705–709
   PubMedGoogle Scholar
• Blake T. J. A. Structure elucidation of drug metabolites using thermospray liquid chromatography-mass spectrometry. Journal of Chromatography 1987; 394: 171–181
   PubMed Web of Science ®Google Scholar
• Chulay J. D., Manson-Bahr P. E. C. Leishmaniasis-Introduction. Hunter's Tropical Medicine 6th edn, G. T. Strickland. W. B. Saunders, Philadelphia 1984; 574–593
   Google Scholar
• Coleman M. D., Mihaly G. W., Ward S. A., Edwards G., Howells R. E., Breckenridge A. M. The disposition of pyrimethamine in the isolated perfused rat liver. Biochemical Pharmacology 1985; 34: 2193–2197
   PubMed Web of Science ®Google Scholar
• Glucuronidation of Drugs and Other Compounds, G. J. Dutton. CRC Press, Boca Raton, Florida 1980; 92
   Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics 2nd edn. Marcel Dekker, New York 1982; 445
   Google Scholar
• Grisham J. W. Use of hepatic cell cultures to detect and evaluate the mechanisms of action of toxic chemicals. International Reviews of Experimental Pathology 1979; 20: 123–210
   PubMedGoogle Scholar
• Kinnamon K. E., Steck E. A., Loizeux W. L., Hanson W. L., Chapman W. L., Jr., Waits V. The antileishmanial activity of lepidines. American Journal of Tropical Medicine and Hygiene 1978; 27: 751–757
   PubMed Web of Science ®Google Scholar
• Korfmacher W. A., Holder C. L., Betowski L. D., Mitchum R. K. Identification of two glucuronide metabolites of doxylamine via thermospray/mass spectrometry and thermospray/mass spectrometry/mass spectrometry. Journal of Analytical Toxicology 1987; 11: 182–184
   PubMed Web of Science ®Google Scholar
• Krone W., Hutter W. B., Kampe S. C., Rittich B., Seitz H. J., Tarnowski W. Long-term perfusion of the isolated rat liver: maintenance of its functional state by use of a fluorocarbon emulsion. Biochemica et Biophysica Acta 1974; 372: 55–71
   PubMedGoogle Scholar
• Fundamentals of Drug Metabolism and Drug Disposition, B. N. LaDu, M. G. Mandel, E. Leong Way. Williams & Wilkins, Baltimore 1972; 402
   Google Scholar
• Liberato D. J., Fenselau C. C., Vestal M. L., Yergey A. L. Characterization of glucuronides with a thermospray liquid chromatography/mass spectrometry interface. Analytical Chemistry 1983; 55: 1741–1744
   PubMed Web of Science ®Google Scholar
• Link C. M., Theoharides A. D., Anders J. C., Chung H., Canfield C. J. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates. Toxicology and Applied Pharmacology 1985; 81: 192–202
   PubMed Web of Science ®Google Scholar
• Marsden P. D. Current concepts in parasitology—leishmaniasis. New England Journal of Medicine 1979; 300: 350–352
   PubMed Web of Science ®Google Scholar
• Mihaly G. W., Smallwood R. A., Anderson J. D., Jones D. B., Webster L. K., Vajda F. J. H2-receptor antagonists and hepatic drug disposition. Hepatology 1982; 2: 828–831
   PubMed Web of Science ®Google Scholar
• Reinke L. A., Kauffman F. C., Belinsky S. A., Thurman R. G. Interactions between ethanol metabolism and mixed-function oxidation in perfused rat liver: inhibition of p-nitroanisole O-demethylation. Journal of Pharmacology and Experimental Therapeutics 1980; 213: 70–78
   PubMed Web of Science ®Google Scholar
• Shipley L. A., Theoharides A. D., Chung H. Interspecies differences in the metabolism of an 8-aminoquinoline antileishmanial drug in isolated hepatocytes. Pharmacologist 1986; 28: 212
   Google Scholar
• Shipley L. A., Theoharides A. D., Chung H. Differential induction of the metabolism of an 8-aminoquinoline antileishmanial drug in hamster microsomes. Federation Proceedings 1987; 46: 697
   Google Scholar
• Sirica A. E., Pitot H. C. Drug metabolism and effects of carcinogens in cultured hepatic cells. Pharmacological Reviews 1980; 31: 205–228
   Web of Science ®Google Scholar
• Strother A., Allahyari R., Buchholz J., Fraser I. M., Tilton B. E. In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite. Drug Metabolism and Disposition 1984; 12: 35–44
   PubMed Web of Science ®Google Scholar
• Theoharides A. D., Anders J. C., Ridder W. E., Smyth M., Chung H. Disposition, pharmacokinetics, and metabolism of a potential antileishmanial drug in Syrian golden hamsters. Federation Proceedings 1984; 43: 959
   Google Scholar
• Theoharides A. D., Chung H., Velazquez H. Metabolism of a potential 8-aminoquinoline antileishmanial drug in rat liver microsomes. Biochemical Pharmacology 1985; 34: 181–188
   PubMed Web of Science ®Google Scholar
• Theoharides A. D., Kim M. M., Ashmore R. W., Shipley L. A. Identification and quantitation of human urinary metabolites of a candidate 8-aminoquinoline antileishmanial drug (WR 6026). Federation Proceedings 1987; 46: 865
   Google Scholar
• Thurman R. G., Kauffman F. C. Factors regulating drug metabolism in intact hepatocytes. Pharmacological Reviews 1979; 31: 229–251
   PubMed Web of Science ®Google Scholar
• Thurman R. G., Marazzo D. P., Jones L. S., Kauffman F. C. The continuous kinetic determination of p-nitroanisole O-demethylation in hemoglobin-free perfused rat liver. Journal of Pharmacology and Experimental Therapeutics 1977; 201: 498–506
   PubMed Web of Science ®Google Scholar
• Wyler D. J., Marsden P. D. Tropical and Geographical Medicine, K. S. Warren, A. A F. Mahmoud. McGraw-Hill, New York 1984; 270
   Google Scholar